[18F]Fluorothymidine PET imaging in the diagnosis of leptomeningeal involvement with diffuse large B-cell lymphoma

Cancer Imaging

Volumn 11, Issue 1, 2011, Pages 140-143

  Holter, Jennifer L ^a   Thorp, Kristin ^a   Smith, M Leann ^a   Kedzierska, Katarzyna ^a   Fung, Kar Ming A ^a   Chacko, George ^b   Swisher, Karen ^a   Robert, Epstein ^a   Gumerlock, Mary K ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b Midwest Medical Isotopes   (United States)

Author keywords

FLT; Fluorothymidine; Leptomeningeal disease; Lymphoma; PET imaging

Indexed keywords

3' FLUOROTHYMIDINE F 18; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; METHOTREXATE; RITUXIMAB; VINCRISTINE; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; 3' FLUOROTHYMIDINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BRAIN INJURY; CANCER CHEMOTHERAPY; CARCINOMATOUS MENINGITIS; CASE REPORT; CHOLECYSTITIS; CLINICAL EVALUATION; DRUG UPTAKE; DRUG WITHDRAWAL; FEMALE; GLOMERULUS FILTRATION RATE; HEADACHE; HUMAN; INTRAOPERATIVE PERIOD; KIDNEY CARCINOMA; KIDNEY FUNCTION; LARGE CELL LYMPHOMA; LIVER; LUNG; MEDIASTINUM; MULTIPLE CYCLE TREATMENT; NEPHRECTOMY; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; PHOTOPHOBIA; POSITRON EMISSION TOMOGRAPHY; SINGLE DRUG DOSE; TEMPORAL LOBE; TUMOR BIOPSY; TUMOR REGRESSION; UPPER ABDOMINAL PAIN; MENINGIOMA; METHODOLOGY; MIDDLE AGED; SCINTISCANNING;

DIDEOXYNUCLEOSIDES; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MENINGEAL NEOPLASMS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 80053454074     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2011.0020     Document Type: Article

References (13)

1. Grisariu S, Avni B, Batchelor TT, et al. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood 2010; 115: 5005-11. doi:10.1182/blood-2009-12-258210.
2. Chamberlain MC. Natural history of CNS relapse in aggressive non-Hodgkin's lymphoma: what have we learned? J Clin Oncol 2009; 27: e26; author reply e27-8. doi:10.1200/JCO.2009.22.0608.
3. Bernstein SH, Unger JM, Leblanc M, et al. Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 - the Southwest Oncology Group. J Clin Oncol 2009; 27: 114-19. doi:10.1200/JCO.2008.16.8021.
4. DeAngelis LM. Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 1998; 38: 245-52. doi:10.1023/A:1005956925637. (Pubitemid 28306215)
5. Freilich RJ, Krol G, DeAngelis LM. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 1995; 38: 51-7. doi:10.1002/ana.410380111.
6. Quijano S, Lopez A, Manuel Sancho J, et al. Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry. J Clin Oncol 2009; 27: 1462-9. doi:10.1200/JCO.2008.17.7089.
7. Walker JG. Diagnosis and management of leptomeningeal disease. Clin J Oncol Nurs 2009; 13: 384-7. doi:10.1188/09.CJON.384-387.
8. Gleissner B, Chamberlain M. Treatment of CNS dissemination in systemic lymphoma. J Neurooncol 2007; 84: 107-17. doi:10.1007/s11060-007-9353-z. (Pubitemid 47103452)
9. DeAngelis LM, Boutros D. Leptomeningeal metastasis. Cancer Invest 2005; 23: 145-54. doi:10.1081/CNV-50458. (Pubitemid 40463913)
10. 18F-FDG. J Nucl Med 2005; 46: 945-52.
11. 18F]FLT-PET in oncology: current status and opportunities. Eur J Nucl Med Mol Imaging 2004; 31: 1659-72. doi:10.1007/s00259-004-1687-6.
12. Chamberlain MC. CNS lymphoma. Neurology 1995; 45: 1233.
13. Nugent JL, Bunn PA, Jr. Matthews MJ, et al. CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer 1979; 44: 1885-93. doi:10.1002/1097-0142(197911)44: 5〈1885::AID-CNCR2820440550〉3.0.CO;2-F. (Pubitemid 10141970)